CommentInactivated influenza vaccines in the elderly—are you sure?
References (11)
- et al.
Efficacy and effectiveness of influenza vaccine in elderly people: a systematic review
Lancet
(2005) - et al.
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy
Lancet Infect Dis
(2007) - et al.
What are the implications of optimism bias in clinical research?
Lancet
(2006) - et al.
Vaccines for preventing influenza in the elderly
Cochrane Database Syst Rev
(2006) Influenza vaccination: policy versus evidence
BMJ
(2006)
Cited by (21)
Influenza vaccination. Seasonal flu or epidemic
2014, VacunasDeaths Preventable in the U.S. by Improvements in Use of Clinical Preventive Services
2010, American Journal of Preventive MedicineCitation Excerpt :This number was summed across all deaths with and without the increased utilization of the intervention and the results were compared. No studies were found estimating the effect of Pap smear screening and colonoscopy on all-cause mortality, and there is substantial concern that currently available estimates of the effect of influenza vaccination on all-cause mortality are biased,8–10 so these three services were modeled using the cause-specific mortality model only. Because smoking increases mortality risks for many different categories of causes, smoking cessation was modeled using the all-cause mortality model only.
Pneumococcal polysaccharide vaccine effectiveness: study quality must not be ignored
2008, The Lancet Infectious DiseasesMortality benefits of influenza vaccination in elderly people
2008, The Lancet Infectious DiseasesThe cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia
2008, VaccineCitation Excerpt :However, in the US it was estimated that influenza is responsible for less than 10% of all-cause winter mortality among the elderly [46]. The inconsistency between these two figures has been widely noted, and the methodological problems associated with cohort studies suggested as the primary explanation [46–51]. This analysis has taken a conservative approach and used a vaccine efficacy for laboratory-confirmed influenza (74% [22]) against only excess hospitalisation and excess mortality attributable to influenza.